Results 161 to 170 of about 84,091 (291)

Bronchiectasis and increased risk of ischemic stroke: a nationwide population-based cohort study

open access: yesInternational Journal of COPD, 2017
Yung-Fu Chen,1–3,* Hsuan-Hung Lin,4,* Chih-Sheng Lin,5 Battsetseg Turbat,1 Kuo-An Wang,4,6 Wei-Sheng Chung1,3,7 1Department of Healthcare Administration, 2Department of Dental Technology and Materials Science, Central Taiwan University of Science ...
Chen YF   +5 more
doaj  

Rituximab and Pirfenidone in the Treatment of Steroid‐Refractory Bleomycin Lung Injury

open access: yesRespirology Case Reports, Volume 13, Issue 7, July 2025.
Bleomycin‐induced lung injury (BILI) is a serious, potentially life‐threatening complication of ABVD chemotherapy. Diagnosis is often challenging and made by exclusion. Treatment becomes particularly difficult when corticosteroids fail, as alternative options are limited.
Aasir M. Suliman   +3 more
wiley   +1 more source

Biomarkers in bronchiectasis

open access: yesEuropean Respiratory Review
Bronchiectasis is a heterogeneous disease with multiple aetiologies and diverse clinical features. There is a general consensus that optimal treatment requires precision medicine approaches focused on specific treatable disease characteristics, known as treatable traits.
Johnson, Emma   +2 more
openaire   +4 more sources

Recurrent Pulmonary Infection Caused by Schizophyllum commune: A Case Report and Management of Inflammation

open access: yesRespirology Case Reports, Volume 13, Issue 7, July 2025.
Schizophyllum commune (SC), commonly known as the oyster mushroom, is a basidiomycete fungus widespread in nature. This case report documents a recurrent pulmonary infection caused by S. commune in a 59‐year‐old woman with repeated admissions for cough and sputum production.
Shuai Ren   +4 more
wiley   +1 more source

ATELECTATIC BRONCHIECTASIS [PDF]

open access: green, 1930
A.J. Scott Pinchin, H. V. Morlock
openalex   +1 more source

Home - About - Disclaimer - Privacy